EXAS vs OFLX · rev $2.76B vs P/E 23, rev $47.1M
EXACT Sciences Corporation (EXAS) versus Omega Flex Inc (OFLX) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Omega Flex Inc (OFLX) is a specialty industrial machinery company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported OFLX revenue for 2026-06-30 was $47.1M. Net income was $4.8M. OFLX currently screens at market cap $304.0M and trailing P/E 22.6.
EXAS currently screens at market cap $20.03B. OFLX currently screens at market cap $304.0M and trailing P/E 22.6.
Not investment advice. Open the EXAS and OFLX stock pages for the full models.
Not investment advice.